Biotechnology, Pharmaceuticals, and Research by TG Therapeutics

  • Hanna Syniavska
  • 10.06.2026
TG Therapeutics stock rises 4.91% as TGTherapeutics CEO set to speak at Goldman Sachs event
TG Therapeutics CEO Mike Weiss will present at the Goldman Sachs 47th Annual Global Healthcare Conference today at 2:00pm ET, according to TG Therapeutics.The company announced the event via a ...
  • Dan Blystone
  • 03.06.2026
TG Therapeutics stock extends weekly slide as downside pressure persists
TG Therapeutics will hold a fireside chat with CEO Mike Weiss at the Jefferies Global Healthcare Conference 2026. The event takes place on Wednesday, June 3 at 11:40 a.m. Eastern Time.The company ...
  • Andreas Kristo
  • 03.06.2026
TG Therapeutics stock under pressure despite Ph1 RMS trial results and supportive technical outlook
TG Therapeutics announced positive results from its Phase 1 trial evaluating the bioavailability of its subcutaneous formulation for adult patients with RMS.Top-line data from the Phase 3 study, ...
  • Daria Chernytska
  • 30.03.2026
TG Therapeutics stock price forecast: overbought readings persist as TGTX consolidates below SMA-200
TG Therapeutics announced that it has secured an additional $500 million in non-dilutive capital from Blue Owl.TG Therapeutics is also expanding its share repurchase program to $300 million. ...